448
Polymyalgia rheumatica (PMR)
classifi cation criteria , 359
clinical diagnostic criteria , 359
clinical guidelines , 357
diagnostic criteria , 359
EULAR response criteria , 361
indication , 357
morning stiffness , 358 , 359 , 361
pain assessment , 359
physical function , 358
PROMs , 361–362
PubMed , 358
Psoriatic arthritis (PsA)
clinical outcomes , 129
DLQI , 133
domains , 128 , 129
fatigue , 134–135
HAQ-DI , 135
impact of , 128
pain , 134
PGA , 133–134
PsAID , 132–133
PsAQoL , 130–132
qualitative methods , 130 , 131
SF-36 , 136
Psoriatic Arthritis Impact of Disease (PsAID) ,
132–133
Psoriatic Arthritis Quality of Life (PsAQoL) ,
130–132
Pulmonary arterial hypertension (PAH) , 299
Q
Quality-Adjusted Life Years (QALY) , 7
R
Raynaud’s condition score (RCS) , 299
Rheumatoid arthritis (RA)
biomarker
implementation , 109
personalized medicine , 110
treat-to-target studies , 110 , 111
comorbidities , 106
condition-specifi c instruments , 107
cost-effectiveness , 106
decision-making process , 112
disease activity , 103
disease-modifying role , 104
ePROMs (see Electronic Patient-Reported
Outcome Measures (ePROMs) )
health outcomes , 101 , 102
infl ammatory arthritis , 101 , 102
multidimensional measurement scale , 107
patient education (see Patient education )
prognostic marker , 104
quantitative measurement , 107
static to dynamic , 108
RheuMetric. See Multidimensional health
assessment questionnaire (MDHAQ)
Routine assessment of patient index data
(RAPID3). See Multidimensional
health assessment questionnaire
(MDHAQ)S
Score for Assessment and Quantifi cation of
Chronic Rheumatic Affections of
the Hands (SACRAH) , 272–273
Short-Form Health Survey (SF-36) , 136 , 294
Six-Item CTS Symptoms Scale (CTS-6) ,
336–337
Sjögren’s syndrome
clinical manifestations , 310
diagnosis , 311
dry eyes
defi nition , 316
IDEEL , 317
the NEI-VFQ , 317
NEI-VFQ-25 , 316
OSDI , 317
Texas Eye Research and Technology
Center , 317
VT-HRQ instruments , 316
dry mouth , 315
ESSDAI , 314 , 320–323
ESSPRI , 313 , 324
fatigue , 318–319
generic tools , 314–315
HRQOL , 314
monitoring response , 312
outcome measures , 319
patient-centered approach , 313
prevalence , 310
progressive systemic disorder , 313
quality of life , 312
slowly progressive pattern , 313
treatment modalities , 311
Spondyloarthritis (SpA)
axSpA
ASAS HI , 127
ASDAS , 125–126
ASQoL , 127
assessment , 123
BASDAI , 124–125
BASFI , 126
clinical symptoms , 123Index